Sodium (R)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylate
| Product Name | Sodium (R)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylate |
|---|---|
| Alternate Names | - Impurities, Impurities of - |
| CAT No. | CS-O-47822 |
| CAS No. | Not Available |
| Category | Impurities |
| Stock | Enquire |
| Mol. Wt. | 202.14 g/mol |
| Mol. For. | C8H7N2NaO3 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
![Picture of Sodium (R)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylate](https://clearsynth.com/structure/Sodium--R--4-oxo-4-6-7-8-tetrahydropyrrolo-1-2-a-pyrimidine-6-carboxylate.png)
Get an Instant Quote
Related Compounds
Ouratea proanthocyanidin A | Ethyl Methyl Sulfide | L-Methyl Glyoxylate Hydrate impurity | Phenyl hydrazine 13C6 HCl | ethyl 2-chloro-2-(2-(4-chlorophenyl)hydrazineylidene)acetate | Safinamide ring closed impurity | N-Nitroso Dimer impurity of Alogliptin | sodium (2-((1R,3S,4aS,4bS,10aS,10bR,11S,12aS)-10b-fluoro-1,11-dihydroxy-3,10a,12a-trimethyl-2,8-dioxo-1,2,3,4,4a,4b,5,6,8,10a,10b,11,12,12a-tetradecahydrochrysen-1-yl)ethyl)phosphonate | Salmeterol Related Compound H | Nintedanib Impurity 63 | N-Formyl Nebivolol | Bis-anhydro-Daunomycinone Carboxylic Acid | N,N-Diethylglycine 2-[2-[(5-chloro-2-nitrophenyl)thio]phenyl]hydrazide | Ethyl (R)-3-(3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanamido)propanoate | Triethyl 1,3,5-benzenetricarboxylate | Sofosbuvir Impurity 94 | Carbomer Interpolymer type A | Methyl 4-bromo-2,2-dimethylbutanoate | Tert-butyl Mirogabalin | Triiodothyroacetic acid sulfate | N-Nitroso N-Desmethyl Dibenzimidazole | methyl 2-(dimethylamino)-2-phenylbutanoate | methyl 4-(6-(5-(2,4-difluorophenylsulfonamido)-6-methoxypyridin-3-yl)quinolin-4-yl)benzoate | Chlorpromazine Hydrochloride - Impurity B | Polybutylene terephthalate Impurity 2 | Quetiapine EP Impurity P diHCl salt | Nandrolone furylpropionate | ONT 993 | N-Nitroso Vilazodone Impurity 3 | Samidorphan methanobenzofuron isoquinoline | GLP-0492-13C,d3 | N,S-(Dicarboxymethyl)cysteine | Neopetasin | N-nitroso-4- hydrazinobenzenesulfonamide | Econazole Related Compound B | eCF506 | Paroxetine Impurity | Methoxy polyethylene glycol succinate N-hydroxy succinimide | Black cohosh | phenylpicolinate | Sorafenib Carboxylic Acid Methyl Ester | Ethyl 3-(dimethyl amino)-2-butenoate | Enzalutamide N-Ethyl Impurity | Maleic anhydride-styrene copolymer | Lithium ((3-(methacryloyloxy)propyl)sulfonyl)((trifluoromethyl)sulfonyl)amide | Tri-p-tolyl Phosphite | Oxo(OtBu)-γ-Glu(α-OtBu)-AEEA-OH | AD-021.32-D6 | Zanubrutinib Dimer impurity | quadrangularin A | Atorvastatin Impurity D ( Mixture of compounds ) | Enzalutamide n-Acetyl impurity | N-propyl cyclooct-2-en-1-amine | Lumefantrine Hydroxy impurity (Mixture of Isomers) | Trans-4-(aminomethyl)-N,N-dimethyl-cyclohexanamine dihydrochloride | Sofosbuvir impurity A | Deformyl Formoterol Citric acid adduct | Amurensin A | Lenumlostat | N-Nitroso Didecylamine (Mixture of Isomers) | Larotrectinib (3S,2S) Sulfate | Cephalosporanic acid G | Heptacarboxylporphyrin I Dihydrochloride | N-(4-(3-ethoxy-2-hydroxypropoxy)phenyl)-3-hydroxypropanamide | Ferric saccharate | Sacubitril Impurity 57 | Gamma-glutamyl-2-naphthylamide | N,N-bis(7-methyloctyl)nitrous amide | Bismuth vanadium oxide | Bromocriptine EP Impurity E |